Improved Identification and Antihypertension Pharmacotherapy in Cardiorenal Metabolic Syndrome: Focus on Racial/Ethnic Minorities, Olmesartan Medoxomil, and Combination Therapy
Keyword(s):
Keyword(s):
2012 ◽
Vol 12
(5)
◽
pp. 325-333
◽
2021 ◽
pp. 100029
Keyword(s):
2010 ◽
Vol 3
(2)
◽
pp. 181-187
◽
Keyword(s):
Keyword(s):
2021 ◽